These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2140606

  • 1. Antineoplastic properties of Maharishi-4 against DMBA-induced mammary tumors in rats.
    Sharma HM, Dwivedi C, Satter BC, Gudehithlu KP, Abou-Issa H, Malarkey W, Tejwani GA.
    Pharmacol Biochem Behav; 1990 Apr; 35(4):767-73. PubMed ID: 2140606
    [Abstract] [Full Text] [Related]

  • 2. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
    Banerjee S, Bueso-Ramos C, Aggarwal BB.
    Cancer Res; 2002 Sep 01; 62(17):4945-54. PubMed ID: 12208745
    [Abstract] [Full Text] [Related]

  • 6. Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress: role of beta-endorphin, prolactin and naltrexone.
    Tejwani GA, Gudehithlu KP, Hanissian SH, Gienapp IE, Whitacre CC, Malarkey WB.
    Carcinogenesis; 1991 Apr 01; 12(4):637-41. PubMed ID: 1901524
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas.
    Iino Y, Takai Y, Sugamata N, Morishita Y.
    Anticancer Res; 1992 Apr 01; 12(6B):2101-3. PubMed ID: 1295453
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis.
    Ip C.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4386-90. PubMed ID: 6796257
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.
    Verma AK, Johnson JA, Gould MN, Tanner MA.
    Cancer Res; 1988 Oct 15; 48(20):5754-8. PubMed ID: 3139283
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Apparent rat strain-related sensitivity to phorbol promotion of mammary carcinogenesis.
    Shellabarger CJ, Holtzman S, Stone JP.
    Cancer Res; 1979 Sep 15; 39(9):3345-8. PubMed ID: 113089
    [Abstract] [Full Text] [Related]

  • 18. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA, Asselin J, Caron MG, Labrie F, Raynaud JP.
    J Natl Cancer Inst; 1977 Mar 15; 58(3):623-8. PubMed ID: 402479
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.